Studies have shown that active fund managers routinely underperform the S&P500 index*​

MDxHealth SA (NASDAQ: MDXH)

MDXH Stock Predictions and Ratings

WSX Rating:
BUY
WSX Forecast (1yr):
9.70%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
400%

MDXH Stock Analysis

MDXH PE Ratio:

MDXH PEG Ratio: Not Available

MDXH Forward EPS Growth (12 month): 0.00%

MDXH PS Ratio: 0.3

MDXH PSG Ratio:

MDXH Forward Revenue Growth (12 month): 15.70%

MDXH Articles

No data was found